相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Matthew Geriak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Ceftaroline fosamil for the treatment of Gram-positive endocarditis: CAPTURE study experience
Christopher J. Destache et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
Pedro Ayau et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Early Administration of Adjuvant -Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis
Anthony M. Casapao et al.
PHARMACOTHERAPY (2017)
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality
Matteo Bassetti et al.
PLOS ONE (2017)
Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia
Warren E. Rose et al.
CLINICAL INFECTIOUS DISEASES (2017)
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial
Joshua S. Davis et al.
CLINICAL INFECTIOUS DISEASES (2016)
When sepsis persists: a review of MRSA bacteraemia salvage therapy
Ravina Kullar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Katie E. Barber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia
Katie E. Barber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA
Katie E. Barber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone
Thomas J. Dilworth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy
Anthony M. Casapao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline
George Sakoulas et al.
CLINICAL THERAPEUTICS (2014)
Daptomycin in Combination With Other Antibiotics for the Treatment of Complicated Methicillin-Resistant Staphylococcus aureus Bacteremia
Abhay Dhand et al.
CLINICAL THERAPEUTICS (2014)
Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality
F. Tissot et al.
JOURNAL OF INFECTION (2014)
Observation of ''Seesaw Effect'' with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains
Katie E. Barber et al.
INFECTIOUS DISEASES AND THERAPY (2014)
Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
Brian J. Werth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Evaluation of Ceftaroline Activity against Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate Methicillin-Resistant S-aureus Strains in an In Vitro Pharmacokinetic/Pharmacodynamic Model: Exploring the Seesaw Effect
Brian J. Werth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the seesaw effect: Taking advantage of the back door left open?
Jessica K. Ortwine et al.
DRUG RESISTANCE UPDATES (2013)
The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients
Jennifer C. Lin et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial Activity
Warren E. Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Altering the Proclivity towards Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Using Combinations with Other Antibiotics
Andrew D. Berti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
Shrenik Mehta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Predictors of Mortality in Staphylococcus aureus Bacteremia
Sebastian J. van Hal et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia
J. O. Robinson et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Elevated Serum Interleukin-10 at Time of Hospital Admission Is Predictive of Mortality in Patients With Staphylococcus aureus Bacteremia
Warren E. Rose et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
分享论文
